Indeed, recent comparative studies examining the pharmacokinetic and pharmacodynamic profiles [36] or the efficacy and safety of ILPS with the other two long-acting insulin analogues [16] suggest that ILPS has a similar glycemic control to glargine and detemir in type 2 diabetes mellitus, out of pregnancy. The gene discussed is INS; the disease is type 2 diabetes mellitus.